Literature DB >> 35575520

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors.

Kali A Smolen1, Arminja N Kettenbach2.   

Abstract

Most cellular processes are regulated by dynamic protein phosphorylation. More than three-quarters of proteins are phosphorylated, and phosphoprotein phosphatases (PPPs) coordinate over 90% of all cellular serine/threonine dephosphorylation. Deregulation of protein phosphorylation has been implicated in the pathophysiology of various diseases, including cancer and neurodegeneration. Despite their widespread activity, the molecular mechanisms controlling PPPs and those controlled by PPPs are poorly characterized. Here, a proteomic approach termed phosphatase inhibitor beads and mass spectrometry (PIB-MS) is described to identify and quantify PPPs, their posttranslational modifications, and their interactors in as little as 12 h using any cell line or tissue. PIB-MS utilizes a non-selective PPP inhibitor, microcystin-LR (MCLR), immobilized on sepharose beads to capture and enrich endogenous PPPs and their associated proteins (termed the PPPome). This method does not require the exogenous expression of tagged versions of PPPs or the use of specific antibodies. PIB-MS offers an innovative way to study the evolutionarily conserved PPPs and expand our current understanding of dephosphorylation signaling.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35575520      PMCID: PMC9297045          DOI: 10.3791/63805

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.424


  25 in total

1.  Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.

Authors:  Mark Swingle; Li Ni; Richard E Honkanen
Journal:  Methods Mol Biol       Date:  2007

2.  Synthesis and use of the protein phosphatase affinity matrices microcystin-sepharose and microcystin-biotin-sepharose.

Authors:  Greg B G Moorhead; Timothy A J Haystead; Carol MacKintosh
Journal:  Methods Mol Biol       Date:  2007

Review 3.  Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates.

Authors:  David L Brautigan; Shirish Shenolikar
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

Review 4.  The PP1 binding code: a molecular-lego strategy that governs specificity.

Authors:  Ewald Heroes; Bart Lesage; Janina Görnemann; Monique Beullens; Luc Van Meervelt; Mathieu Bollen
Journal:  FEBS J       Date:  2012-03-21       Impact factor: 5.542

5.  Comet: an open-source MS/MS sequence database search tool.

Authors:  Jimmy K Eng; Tahmina A Jahan; Michael R Hoopmann
Journal:  Proteomics       Date:  2012-12-04       Impact factor: 3.984

6.  Quantitative kinase and phosphatase profiling reveal that CDK1 phosphorylates PP2Ac to promote mitotic entry.

Authors:  Isha Nasa; Lauren E Cressey; Thomas Kruse; Emil P T Hertz; Jiang Gui; Lee M Graves; Jakob Nilsson; Arminja N Kettenbach
Journal:  Sci Signal       Date:  2020-09-08       Impact factor: 8.192

7.  Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors.

Authors:  Susan Klaeger; Bjoern Gohlke; Jessica Perrin; Vipul Gupta; Stephanie Heinzlmeir; Dominic Helm; Huichao Qiao; Giovanna Bergamini; Hiroshi Handa; Mikhail M Savitski; Marcus Bantscheff; Guillaume Médard; Robert Preissner; Bernhard Kuster
Journal:  ACS Chem Biol       Date:  2016-02-25       Impact factor: 5.100

Review 8.  Protein phosphatase 2A regulatory subunits and cancer.

Authors:  Pieter J A Eichhorn; Menno P Creyghton; René Bernards
Journal:  Biochim Biophys Acta       Date:  2008-06-03

9.  A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans.

Authors:  Scott P Lyons; Nicole P Jenkins; Isha Nasa; Meng S Choy; Mark E Adamo; Rebecca Page; Wolfgang Peti; Greg B Moorhead; Arminja N Kettenbach
Journal:  Mol Cell Proteomics       Date:  2018-09-18       Impact factor: 5.911

10.  Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia.

Authors:  Matthew J Cooper; Nathan J Cox; Eric I Zimmerman; Brian J Dewar; James S Duncan; Martin C Whittle; Thien A Nguyen; Lauren S Jones; Sreerupa Ghose Roy; David M Smalley; Pei Fen Kuan; Kristy L Richards; Richard I Christopherson; Jian Jin; Stephen V Frye; Gary L Johnson; Albert S Baldwin; Lee M Graves
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.